BDBM50412718 CHEMBL509819

SMILES CC[C@H](C)[C@H](NC(=O)[C@H](CC(C)C)NC(=O)c1ccco1)C(=O)NCC(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCN)C(N)=O

InChI Key InChIKey=FARMTEBRNBOKQJ-UHFFFAOYSA-N

Data  1 IC50  7 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 8 hits for monomerid = 50412718   

TargetProteinase-activated receptor 2(Human)
Acadia Pharmaceuticals

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50412718BDBM50412718(CHEMBL509819)
Affinity DataEC50:  25.1nMAssay Description:Agonist activity at human PAR2 expressed in HEK293T cells assessed as effect on intracellular calcium mobilization by R-SAT assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
5/21/2013
Entry Details Article
PubMed
TargetProteinase-activated receptor 2(Human)
Acadia Pharmaceuticals

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50412718BDBM50412718(CHEMBL509819)
Affinity DataIC50: 100nMAssay Description:Displacement of [3H]-2-furoyl-LIGRL-NH2 from human PAR2 expressed in human NCTC-2544 cells after 60 mins by scintillation counting analysisMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetProteinase-activated receptor 2(Human)
Acadia Pharmaceuticals

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50412718BDBM50412718(CHEMBL509819)
Affinity DataEC50:  150nMAssay Description:Agonist activity at human PAR2 expressed in HEK293T cells assessed as induction of Galphaq-stimulated IP1 formation incubated for 2 hrs by FRET assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed
TargetProteinase-activated receptor 2(Human)
Acadia Pharmaceuticals

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50412718BDBM50412718(CHEMBL509819)
Affinity DataEC50:  200nMAssay Description:Agonist activity at PAR2 in human HT-29 cells assessed as increase in intracellular calcium releaseMore data for this Ligand-Target Pair
In Depth
Date in BDB:
4/13/2014
Entry Details Article
PubMed
TargetProteinase-activated receptor 2(Human)
Acadia Pharmaceuticals

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50412718BDBM50412718(CHEMBL509819)
Affinity DataEC50:  300nMAssay Description:Agonist activity at human PAR2 expressed in CHO cells assessed as induction of intracellular calcium release measured for 300 secs by Fluo-3 AM dye-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/6/2019
Entry Details Article
PubMed
TargetProteinase-activated receptor 2(Human)
Acadia Pharmaceuticals

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50412718BDBM50412718(CHEMBL509819)
Affinity DataEC50:  316nMAssay Description:Agonist activity at human PAR2 expressed in CHO cells assessed as induction of intracellular calcium release measured for 300 secs by Fluo-3 AM dye-b...More data for this Ligand-Target Pair
In Depth
Date in BDB:
6/6/2019
Entry Details Article
PubMed
TargetProteinase-activated receptor 2(Human)
Acadia Pharmaceuticals

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50412718BDBM50412718(CHEMBL509819)
Affinity DataEC50:  350nMAssay Description:Agonist activity at PAR2 in human EA.hy926 cells assessed as stimulation of calcium mobilization by Fluo-4-AM dye-based FLIPR assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/25/2022
Entry Details Article
PubMed
TargetProteinase-activated receptor 2(Human)
Acadia Pharmaceuticals

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50412718BDBM50412718(CHEMBL509819)
Affinity DataEC50:  430nMAssay Description:Agonist activity at PK1-tagged PAR2 (unknown origin) expressed in HEK293 cells assessed as induction of beta-arrestin recruitment incubated for 90 mi...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/13/2021
Entry Details Article
PubMed